Subscribe

RSSAdd blog to your RSS reader

All Topics

Contact Us

212.451.2258

ADVERTISING@OLSHANLAW.COM

Advertising Law Blog

The Advertising Law Blog provides commentary and news on developing legal issues in advertising, promotional marketing, Internet, and privacy law. This blog is sponsored by the Advertising, Marketing & Promotions group at Olshan. The practice is geared to servicing the needs of the advertising, promotional marketing, and digital industries with a commitment to providing personal, efficient and effective legal service.

Showing 11 posts in FDA.

What Does the Farm Bill Mean for CBD/Hemp Products?

The recently enacted Farm Bill amends the Controlled Substances Act so that  hemp and CBD products containing trace amount of THC are not classified as Schedule 1 controlled substances.    While many are excited about this amendment, the law does not change FDA’s regulatory requirements for CBD-containing products under its regulatory jurisdiction. Read More ›

FDA Issues Further Warning Letter to E-Liquid Company

The FDA and FTC together have recently issued 13 warning letters to manufacturers, distributors, and retailers, cautioning against the sale of e-liquids for use in e-cigarettes using labeling and/or advertising that is similar to that which is found on children’s food products, like juice boxes, candies, or cookies.  The warning letters were sent in furtherance of the FDA and FTC’s efforts to protect young people from the dangers of nicotine and tobacco products.  Read More ›

Jelly Belly Sued for Failing to Adequately Disclose the Presence of Sugar in Its “Sports Beans”

With consumers ever more ingredient-conscious, brands must be careful of how they describe them, particularly when the product may be positioned as a “healthy” version. Read More ›

FDA Seeks to Redefine what “Healthy” Actually Means

What the FDA considers “healthy” remains a major source of contention. The FDA has started a public process to redefine the “healthy” claim on food labeling to update existing food choices which will hopefully bring clarity to the issue. Read More ›

FDA Steps Up Enforcement on Unapproved Dietary Supplement Claims

FDA regulations prohibit making drug claims for dietary supplement products even if such claims are supported by scientific evidence. A recent FDA enforcement action involving dietary supplement products promoted to address high cholesterol, hypertension, diabetes, depression and muscle pain claims show that the agency is prepared to take significant steps where manufacturers continue to make drug claims for dietary supplement products, particularly where the facility fails to meet CGMP requirements. Read More ›

FDA Announces Amendment to Domestic and Foreign Food Facility Registration

A Final Rule has been issued by the FDA amending its regulations for registration of foreign and domestic food facilities. Read More ›

FDA Permits Limited Use of the Term “Healthy”On Food Labels

FDA issued letters to KIND, LLC over its use of the terms "healthy and tasty" in connection with its listing of product ingredients. Read More ›

Andrew Lustigman Quoted in Bloomberg’s Electronic Commerce & Law Report

Olshan Advertising, Marketing & Promotions Practice Group Leader Andrew Lustigman was extensively quoted in the Electronic Commerce & Law Report published by Bloomberg BNA addressing the outlook of social media advertising.  Read More ›

OMG! Kim Kardashian Warning Letter Sends Wake Up Call to Brands To Actively Monitor Social Media Posts

Brands must actively monitor the posts by social media influencers, particularly where there is a business relationship, either directly or indirectly, between them. Read More ›

Back to Page